DocWire News Editors

DocwireNews

In in vitro and in vivo preclinical models, the combination of magrolimab with venetoclax plus azacitidine increased phagocytosis and prolonged survival in AML cells, according to research presented at the 2021 ASH Annual Meeting. The findings were reported by lead author Yannan Jia, from the Department of Leukemia at the University of Texas MD Anderson Cancer Center in Houston.
Magrolimab targets CD47, a macrophage immune checkpoint that functions as a “don’t eat me” signal on cancer cells by binding SIRPa on macrophages and blocking phagocytosis, the researchers explained. Cancer cells evade phagocytosis by overexpressing CD47, and high CD47 expression in AML has been associated with inferior outcomes.
In the present preclinical study, Ms. Jia and coauthors evaluated whether blocking CD47 via magrolimab, when combined with the BCL2 inhibitor venetoclax and the hypomethylating agent azacitidine could create a synergistic effect to induce “eat me” signals on leukemic blasts, thereby enhancing phagocytosis.
First, the investigators tested the combined efficacy of magrolimab and venetoclax plus azacitidine in vitro in a phagocytosis assay, using monocytes isolated from seven healthy donors. The combination appeared to significantly increase phagocytosis, not only in parental but also in venetoclax-resistant and p53-mutant cells, when compared with either treatment alone. “Further proteomics studies to identify additional ‘eat me’ signals following venetoclax-azacitidine treatment are ongoing,” the authors reported.
Next, the researchers examined the therapeutic efficacy of magrolimab alone or in combination with venetoclax-azacitidine in AML patient-derived xenografts models. Results from mouse models revealed that magrolimab reduced leukemia burden, delayed leukemia progression, and significantly extended survival. However, venetoclax-azacitidine alone had no or minimal impact on tumor burden or survival.
Given these findings, investigators have launched a clinical trial of the magrolimab and venetoclax-azacitidine combination, which has shown high rates of preliminary efficacy, the authors noted.

Jordana Jampel

Association Between Headache Diagnosis and Suicide Incidence in Danish Population Study

Neurology

Molecular Structure of Apolipoprotein B100 Discovered

Preventive Cardiology

Laura Litwin

Preventing POAF: Partial Cardiac Denervation After CABG Reduces Incidence Without Increasing Complications

Atrial Fibrillation

Latest News

Preclinical Model Shows Promise of Magrolimab Plus Venetoclax-Azacitidine in AML

ASH Annual Meeting and Exposition 2021

In in vitro and in vivo preclinical models, the combination of magrolimab with venetoclax plus azacitidine increased phagocytosis and prolonged survival in AML cells, ...

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe